Home Urology August 2015 Briefing – Urology

August 2015 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for August 2015. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

FRIDAY, Aug. 28, 2015 (HealthDay News) — The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients, according to a report published by the American Medical Association (AMA).

Sleep Deprived Surgeons Appear to Be Self-Regulating Well

THURSDAY, Aug. 27, 2015 (HealthDay News) — The risk of death, hospital readmission, or complications following surgery is no more likely if the surgeon worked a midnight shift before a daytime operation, according to a study published in the Aug. 27 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin

THURSDAY, Aug. 27, 2015 (HealthDay News) — For most atrial fibrillation patients taking warfarin who require temporary interruption for a procedure, perioperative bridging with heparin is unnecessary, according to a study published in the Aug. 27 issue of the New England Journal of Medicine.

Too Few Blacks, Hispanics Pursuing Careers As Physicians

TUESDAY, Aug. 25, 2015 (HealthDay News) — Too few members of certain minority groups are pursuing careers in U.S. medicine, resulting in a serious lack of diversity among general practitioners and specialists, according to a research letter published online Aug. 24 in JAMA Internal Medicine.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Circulating Tumor Cell Assays May Play Role in Managing Bladder CA

TUESDAY, Aug. 25, 2015 (HealthDay News) — Circulating tumor cell assays may have a role in the management of bladder cancer, according to a study published in the September issue of The Journal of Urology.

Ureteric Injury Risk With Hysterectomy Up 2001 to 2010

MONDAY, Aug. 24, 2015 (HealthDay News) — In 2001 to 2010, 0.5 percent of women experienced ureteric injury in the year after a hysterectomy, with lower rates for benign versus malignant conditions and rates of injury increasing between 2001 and 2010, according to a study published online Aug. 18 in BJOG: An International Journal of Obstetrics and Gynaecology.

Patient, Family Advisors Can Play Key Role in Practices

FRIDAY, Aug. 21, 2015 (HealthDay News) — Practices can employ patient and family advisors in order to help them focus on patient-centered care needs, according to a report published by the American Medical Association (AMA).

Report Highlights Ways to Improve Physician Resilience

THURSDAY, Aug. 20, 2015 (HealthDay News) — Strategies can be adopted for improving physician resilience and the ability to handle the challenges presented by patient care, according to a report published by the American Medical Association (AMA).

Heart Safety of Testosterone Unclear for Older Men

WEDNESDAY, Aug. 19, 2015 (HealthDay News) — Trials should be conducted to better establish the cardiovascular safety of testosterone therapy, according to a perspective piece published in the Aug. 20 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Most Patients Undergo Follow-Up After Pediatric Pyeloplasty

WEDNESDAY, Aug. 19, 2015 (HealthDay News) — Most patients are followed up after pediatric pyeloplasty, with ultrasound being the most common imaging modality, according to a study published in the September issue of The Journal of Urology.

Smoking Ups Risk of Some Renal Cell Cancer Histological Subtypes

MONDAY, Aug. 17, 2015 (HealthDay News) — Smoking is a risk factor for clear cell and papillary renal cell carcinoma, but not for the chromophobe subtype, according to a study published in the September issue of The Journal of Urology.

Ultrasound Overused for Undescended Testicle Care

FRIDAY, Aug. 14, 2015 (HealthDay News) — Ultrasound has limited value for the management of an undescended testicle (UDT), but remains widely overused, according to a study published online Aug. 10 in Pediatrics.

More Physicians Reporting Dissatisfaction With EHR Systems

THURSDAY, Aug. 13, 2015 (HealthDay News) — More physicians report being dissatisfied or very dissatisfied with their electronic health record (EHR) system, compared with five years ago, according to a report published by the AmericanEHR Partners and the American Medical Association.

HAC Reduction Program Penalty Kicks in for FY2015

TUESDAY, Aug. 11, 2015 (HealthDay News) — The latest Centers for Medicare & Medicaid Services (CMS) effort to reduce hospital-acquired conditions (HACs) is the HAC Reduction Program, according to an Aug. 6 health policy brief published in Health Affairs.

Full Text

In-Person Staff Meetings Are Valuable for Health Care Teams

MONDAY, Aug. 10, 2015 (HealthDay News) — In-person staff meetings, which are not too short or too long and are held frequently, are valuable for health care team operation, according to an article published in Medical Economics.

Many Hospitals Being Penalized for 30-Day Readmissions

FRIDAY, Aug. 7, 2015 (HealthDay News) — About half of the nation’s hospitals are being penalized by Medicare for having patients return within a month of discharge, losing a combined $420 million, according to a report published by Kaiser Health.

New Rx Strategy May Up Survival in Advanced Prostate Cancer

THURSDAY, Aug. 6, 2015 (HealthDay News) — Chemotherapy at the start of androgen-deprivation therapy (ADT) can extend the lives of men with metastatic, hormone-sensitive prostate cancer, according to research published online Aug. 5 in the New England Journal of Medicine.

Robotic Sx Feasible for Inferior Vena Cava Thrombectomy

TUESDAY, Aug. 4, 2015 (HealthDay News) — Completely intracorporeal robotic level III inferior vena cava tumor thrombectomy is feasible, according to a report published recently in The Journal of Urology.

Copyright © 2015 ScoutNews, LLC. All rights reserved.